Literature DB >> 26214024

How genetics affects the brain to produce higher-level dysfunctions in myotonic dystrophy type 1.

Laura Serra, Antonio Petrucci, Barbara Spanò, Mario Torso, Giusy Olivito, Ludovico Lispi, Sandro Costanzi-Porrini, Giovanni Giulietti, Giacomo Koch, Manlio Giacanelli, Carlo Caltagirone, Mara Cercignani, Marco Bozzali.   

Abstract

Myotonic dystrophy type 1 (DM1) is a multisystemic disorder dominated by muscular impairment and brain dysfunctions. Although brain damage has previously been demonstrated in DM1, its associations with the genetics and clinical/neuropsychological features of the disease are controversial. This study assessed the differential role of gray matter (GM) and white matter (WM) damage in determining higher-level dysfunctions in DM1. Ten patients with genetically confirmed DM1 and 16 healthy How genetics affects the brain to produce higher-level dysfunctions in myotonic dystrophy type 1 matched controls entered the study. The patients underwent a neuropsychological assessment and quantification of CTG triplet expansion. All the subjects underwent MR scanning at 3T, with studies including T1-weighted volumes and diffusion-weighted images. Voxel-based morphometry and tractbased spatial statistics were used for unbiased quantification of regional GM atrophy and WM integrity. The DM1 patients showed widespread involvement of both tissues. The extent of the damage correlated with CTG triplet expansion and cognition. This study supports the idea that genetic abnormalities in DM1mainly target the WM, but GM involvement is also crucial in determining the clinical characteristics of DM1.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26214024      PMCID: PMC4520669     

Source DB:  PubMed          Journal:  Funct Neurol        ISSN: 0393-5264


  46 in total

1.  Unified segmentation.

Authors:  John Ashburner; Karl J Friston
Journal:  Neuroimage       Date:  2005-04-01       Impact factor: 6.556

2.  The B-matrix must be rotated when correcting for subject motion in DTI data.

Authors:  Alexander Leemans; Derek K Jones
Journal:  Magn Reson Med       Date:  2009-06       Impact factor: 4.668

3.  Threshold-free cluster enhancement: addressing problems of smoothing, threshold dependence and localisation in cluster inference.

Authors:  Stephen M Smith; Thomas E Nichols
Journal:  Neuroimage       Date:  2008-04-11       Impact factor: 6.556

4.  In vivo definition of parieto-motor connections involved in planning of grasping movements.

Authors:  Giacomo Koch; Mara Cercignani; Cristiano Pecchioli; Viviana Versace; Massimiliano Oliveri; Carlo Caltagirone; John Rothwell; Marco Bozzali
Journal:  Neuroimage       Date:  2010-02-13       Impact factor: 6.556

5.  Quantitative magnetization transfer provides information complementary to grey matter atrophy in Alzheimer's disease brains.

Authors:  Giovanni Giulietti; Marco Bozzali; Viviana Figura; Barbara Spanò; Roberta Perri; Camillo Marra; Giordano Lacidogna; Franco Giubilei; Carlo Caltagirone; Mara Cercignani
Journal:  Neuroimage       Date:  2011-10-01       Impact factor: 6.556

Review 6.  Regional grey matter loss and brain disconnection across Alzheimer disease evolution.

Authors:  M Bozzali; A Padovani; C Caltagirone; B Borroni
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

7.  White matter abnormalities and neurocognitive correlates in children and adolescents with myotonic dystrophy type 1: a diffusion tensor imaging study.

Authors:  Jeffrey R Wozniak; Bryon A Mueller; Erin E Ward; Kelvin O Lim; John W Day
Journal:  Neuromuscul Disord       Date:  2010-12-18       Impact factor: 4.296

8.  Regional brain atrophy and functional disconnection across Alzheimer's disease evolution.

Authors:  T Gili; M Cercignani; L Serra; R Perri; F Giove; B Maraviglia; C Caltagirone; M Bozzali
Journal:  J Neurol Neurosurg Psychiatry       Date:  2010-07-16       Impact factor: 10.154

9.  Short-term retrospective versus prospective memory processing as emergent properties of the mind and brain: human fMRI evidence.

Authors:  L W Mok
Journal:  Neuroscience       Date:  2012-09-12       Impact factor: 3.590

10.  Brain involvement in myotonic dystrophies: neuroimaging and neuropsychological comparative study in DM1 and DM2.

Authors:  Vincenzo Romeo; E Pegoraro; C Ferrati; F Squarzanti; G Sorarù; A Palmieri; P Zucchetta; L Antunovic; E Bonifazi; G Novelli; C P Trevisan; M Ermani; R Manara; C Angelini
Journal:  J Neurol       Date:  2010-03-11       Impact factor: 4.849

View more
  19 in total

1.  Brain gray matter structural network in myotonic dystrophy type 1.

Authors:  Atsuhiko Sugiyama; Daichi Sone; Noriko Sato; Yukio Kimura; Miho Ota; Norihide Maikusa; Tomoko Maekawa; Mikako Enokizono; Madoka Mori-Yoshimura; Yasushi Ohya; Satoshi Kuwabara; Hiroshi Matsuda
Journal:  PLoS One       Date:  2017-11-02       Impact factor: 3.240

Review 2.  Myotonic Dystrophies: State of the Art of New Therapeutic Developments for the CNS.

Authors:  Genevieve Gourdon; Giovanni Meola
Journal:  Front Cell Neurosci       Date:  2017-04-20       Impact factor: 5.505

3.  Cognitive Deficits, Apathy, and Hypersomnolence Represent the Core Brain Symptoms of Adult-Onset Myotonic Dystrophy Type 1.

Authors:  Jacob N Miller; Alison Kruger; David J Moser; Laurie Gutmann; Ellen van der Plas; Timothy R Koscik; Sarah A Cumming; Darren G Monckton; Peggy C Nopoulos
Journal:  Front Neurol       Date:  2021-07-01       Impact factor: 4.003

4.  "I Know that You Know that I Know": Neural Substrates Associated with Social Cognition Deficits in DM1 Patients.

Authors:  Laura Serra; Mara Cercignani; Michela Bruschini; Lisa Cipolotti; Matteo Mancini; Gabriella Silvestri; Antonio Petrucci; Elisabetta Bucci; Giovanni Antonini; Loretta Licchelli; Barbara Spanò; Manlio Giacanelli; Carlo Caltagirone; Giovanni Meola; Marco Bozzali
Journal:  PLoS One       Date:  2016-06-03       Impact factor: 3.240

5.  Brain Connectomics' Modification to Clarify Motor and Nonmotor Features of Myotonic Dystrophy Type 1.

Authors:  Laura Serra; Matteo Mancini; Gabriella Silvestri; Antonio Petrucci; Marcella Masciullo; Barbara Spanò; Mario Torso; Chiara Mastropasqua; Manlio Giacanelli; Carlo Caltagirone; Mara Cercignani; Giovanni Meola; Marco Bozzali
Journal:  Neural Plast       Date:  2016-05-25       Impact factor: 3.599

6.  Relationship of white and gray matter abnormalities to clinical and genetic features in myotonic dystrophy type 1.

Authors:  Stefano Zanigni; Stefania Evangelisti; Maria Pia Giannoccaro; Federico Oppi; Roberto Poda; Antonio Giorgio; Claudia Testa; David Neil Manners; Patrizia Avoni; Laura Ludovica Gramegna; Nicola De Stefano; Raffaele Lodi; Caterina Tonon; Rocco Liguori
Journal:  Neuroimage Clin       Date:  2016-05-03       Impact factor: 4.881

7.  Neuropsychological and Psychological Functioning Aspects in Myotonic Dystrophy Type 1 Patients in Italy.

Authors:  Edward Callus; Enrico G Bertoldo; Maria Beretta; Sara Boveri; Rosanna Cardani; Barbara Fossati; Elisa Brigonzi; Giovanni Meola
Journal:  Front Neurol       Date:  2018-09-19       Impact factor: 4.003

Review 8.  Current Progress in CNS Imaging of Myotonic Dystrophy.

Authors:  Martina Minnerop; Carla Gliem; Cornelia Kornblum
Journal:  Front Neurol       Date:  2018-08-21       Impact factor: 4.003

9.  Diffusion tensor imaging and voxel-based morphometry reveal corticospinal tract involvement in the motor dysfunction of adult-onset myotonic dystrophy type 1.

Authors:  Jin-Sung Park; Huijin Song; Kyung Eun Jang; Hyunsil Cha; Sang-Hoon Lee; Su-Keong Hwang; Donghwi Park; Hui Joong Lee; Jun-Young Kim; Yongmin Chang
Journal:  Sci Rep       Date:  2018-10-22       Impact factor: 4.379

10.  Outcome Measures for Central Nervous System Evaluation in Myotonic Dystrophy Type 1 May Be Confounded by Deficits in Motor Function or Insight.

Authors:  Mark J Hamilton; John McLean; Sarah Cumming; Bob Ballantyne; Josephine McGhie; Ravi Jampana; Cheryl Longman; Jonathan J Evans; Darren G Monckton; Maria Elena Farrugia
Journal:  Front Neurol       Date:  2018-10-02       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.